These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2743354)

  • 1. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY; Staren ED; Tereshkova N; Braun DP
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ; House D
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
    Kurosu Y; Saegusa Y; Tominaga M; Morita K
    Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients.
    Khuri N; Jothy SP; Shibata HR
    Can J Surg; 1989 Jan; 32(1):23-6. PubMed ID: 2463069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer.
    Ishigami S; Natsugoe S; Miyazono F; Tokuda K; Nakajo A; Matsumoto M; Okumura H; Nakashima S; Hokita S; Maruyama I; Aikou T
    Anticancer Res; 2004; 24(3b):2123-6. PubMed ID: 15274412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of phenotype of blood lymphocyte subsets prior and after PWM stimulation in patients with lung carcinoma.
    Jezewska E; Górny MK; Skrzypczak A; Słowik-Gabryelska A; Zeromski J
    Arch Geschwulstforsch; 1989; 59(1):31-6. PubMed ID: 2923522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer.
    Mantovani G; Maccio A; Zucca MV; Serra MC; Proto E; Locci F; Arangino V; Manduco D; Sulis G; Puxeddu P
    J Biol Regul Homeost Agents; 1989; 3(1):25-34. PubMed ID: 2786668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
    Morikawa Y; Watanabe S; Kodama T
    Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
    Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
    J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.